Allogeneic HSCT ( DrugBank: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
65	原発性免疫不全症候群	2

65. 原発性免疫不全症候群

臨床試験数 : 482 / 薬物数 : 653 - (DrugBank : 119) / 標的遺伝子数 : 92 - 標的パスウェイ数 : 212

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04339777 (ClinicalTrials.gov)	September 22, 2020	8/4/2020	Allogeneic Hematopoietic Stem Cell Transplant for People With Primary Immunodeficiency Diseases	A Phase II Study of Allogeneic Hematopoietic Stem Cell Transplant for Patients With Primary Immunode ...	Lymphoproliferative Disorders;Autoimmune Lymphoproliferative;Immune System Diseases;Common Variable ...	Drug: Busulfan test dose;Drug: Fludarabine;Drug: Busulfan;Drug: Alemtuzumab;Radiation: Total body Ir ...	National Cancer Institute (NCI)	NULL	Suspended	4 Years	69 Years	All	10	Phase 2	United States
2	EUCTR2018-001029-14-FR (EUCTR)	25/10/2018	02/07/2018	HTLP	A phase I/II Study evaluating the safety and the efficacy of Human T Lymphoid Progenitor (HTLP) inje ...	SCID pediatric patients (n=12 for analysis) requiring an HLA partially compatible allogeneic HSCT. M ...	Product Name: HTLP Product Code: HTLP	ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	12	Phase 1;Phase 2	France

First Previous1Next Last